Strategic Partners

Partnerships to be proud of.

We have forged strategic partnerships with leading companies around the world. Our operating model allows us to leverage our strengths globally, while enjoying local market expertise, whether it is a US state’s medical marijuana program or one of many regulated international markets.  We can act with unmatched speed and agility in reaction to evolving market conditions to reach our goal of improving the lives of as many people around the world as we can.   

Ultra Health is New Mexico’s top medical cannabis grower with over 30% of local market share.

The company aims to provide New Mexico residents with easier access to the cutting-edge products for therapeutic needs. Ultra Health carries a variety of medical cannabis strains and products including concentrates, topicals, edibles, THC and CBD products, as well as delivery systems. Panaxia and Ultra Health announced their partnership in March 2016 and within a year launched their first pharmaceutical cannabis production facility in Bernalillo, New Mexico.

Salus Biopharma’s mission is to provide medical cannabis products developed with cutting edge technologies to the highest available pharmacy standards. The Company manufactures and markets pharmacy grade cannabis based products developed with partner Panaxia Industries Inc. All products  are manufactured to GMP standards and provide accurate, specific and reproducible dosing. Salus Biopharma is a wholly-owned subsidiary of MPX Bioceutical Corporation.

MPX Bioceutical Corporation (formerly BCC) aims to become one of the largest players in the adult cannabis industry. MPX Bioceutical Corporation owns subsidiaries in the United States, and provides management, staff, advisory, financial, procurement and administrative services to two ventures in Arizona. MPX Bioceutical Corporation provides the support necessary for its partners to successfully market their therapeutic cannabis partners. Panaxia and MPX Bioceutical Corporation announced their partnership in Summer 2017. Under the agreement, Panaxia will provide smokeless, pharma-grade products that are not easily obtainable in the United States.

BGM a privately owned Biotechnology company in the Republic of South Africa located in the City of Johannesburg, the technological hub and business innovation centre of South Africa.

BGM recognises the need for the development of new therapies as well as improvement of existing therapies. BGM is committed to investing significantly into various research programmes that will empower future generation.

Ocean Grown Ventures offers the highest-quality cannabis-derived wellness solutions to the U.S. market and beyond by meeting standards usually reserved for pharmaceutical companies. Through its exclusive partnership with renowned Israeli pharmaceutical pioneer Panaxia Pharmaceutical Industries, Ocean Grown Ventures has sales and distribution rights to consistent and proprietary formulations that meet current Good Manufacturing Practices (GMP) standards. The Company applies Panaxia’s world-class scientific expertise to develop and market formulations that offer customized and accessible solutions. Ocean Grown Ventures is headquartered in Los Angeles, California. For more information, or to inquire about white-label opportunities, please visit Ocean Grown Ventures’ website at

Rafa is a pharmaceutical company in Israel that markets, manufactures and distributes prescription (Rx) and over-the-counter (OTC) medicines, mainly proprietary formulations, as well as generic formulations, and consumer health products.

With a history of over 80 years, Rafa is a trusted partner of some of the leading pharmaceutical companies, such as Mundipharma, Napp, Purdue, Galderma, Takeda, AstraZeneca, Dr. Falk Pharma, Helsinn and more. All companies operate under safety, development and manufacturing global standards.

Pharmocann is one of the pioneering companies in Israel’s vast pharmaceutical cannabis industry.

Pharmocann’s farm was established nearly a decade ago in the Jezreel Valley in Israel’s north and sits on 8 acres of land.

The company produces ten strains of medical cannabis and has the capacity to produce two tons of product a year, reaching 3,000 patients.

Seach Medical Cannabis Group is a family based company, part of agriculture farm based in Hasharon area in Israel which has been active in the agriculture field for more than 70 years. Seach is a pioneer player in the medical Cannabis field in Israel and worldwide. For more than a decade, Seach has been growing and supplying medical Cannabis to thousands of patients in Israel, to the Israeli ministry of health and to research institutions. Seach owns a 14,000 SqM medical Cannabis farm equipped with fully automated greenhouse and research facilities. Seach is currently supplying 13 unique strains of the plant, designated for treatments of various medical indications. In addition, Seach is constantly involved in breeding and development of additional strains and technologies in the medical Cannabis field.



TevaAdir is a medical cannabis supplier with farms located in Israel’s sunny southern region, near the city of Eilat and the Red Sea.

The company’s crops are grown with all-natural ingredients to deliver the highest quality product. TevaAdir offers both pure and hybrid strains to cater to a variety of solutions.


Better has over 15 years of experience and knowledge in production of cannabis strains for medical usage. Specializing in organic growing techniques and developing unique products for different delivery system, Better has become one of the first and largest producers of Medical Grade Cannabis in Israel and is expanding to the global market to create a Better world.

Cann10 is an active member of the medical cannabis industry. With offices and activities in more than 10 countries, Cann10 is also licensed in Israel to produce and will trade in medical cannabis. We are involved in growing, producing, marketers and we help investors make the right decisions. We understand every phase of medical cannabis from field to dispensary; from growing to marketing; and from science to helping people live a better life. Cann10 manage, invests and develops startups involved in the medical cannabis ecosystem through the Cann10XL accelerator. Cann10 will provide high-quality cannabis, cannabis derivatives, and other products and services to medical dispensaries and directly to patients, as well as to pharmaceutical companies and for scientific research, around the world with the Cann10 brand “Cannareet”.
Close Menu